These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23547940)

  • 1. Mortality among British Columbians testing for hepatitis C antibody.
    Yu A; Spinelli JJ; Cook DA; Buxton JA; Krajden M
    BMC Public Health; 2013 Apr; 13():291. PubMed ID: 23547940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
    Filho HRM; Bierrenbach ALS; Capuani MLD; Mendrone A; Benzaken AS; Machado SM; Saivish MV; Sabino EC; Witkin SS; Mendes-Corrêa MC
    PLoS One; 2019; 14(12):e0226566. PubMed ID: 31856222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
    Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
    Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
    Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M
    PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
    Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
    EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
    Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
    Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
    J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia.
    Buxton JA; Rothon D; Durigon M; Lem M; Tu AW; Remple VP; Cook D; Krajden M
    Can J Public Health; 2009; 100(2):121-4. PubMed ID: 19839288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 45-year follow-up of hepatitis C virus infection in healthy young adults.
    Seeff LB; Miller RN; Rabkin CS; Buskell-Bales Z; Straley-Eason KD; Smoak BL; Johnson LD; Lee SR; Kaplan EL
    Ann Intern Med; 2000 Jan; 132(2):105-11. PubMed ID: 10644270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV co-infection in HIV positive population in British Columbia, Canada.
    Buxton JA; Yu A; Kim PH; Spinelli JJ; Kuo M; Alvarez M; Gilbert M; Krajden M
    BMC Public Health; 2010 Apr; 10():225. PubMed ID: 20429917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019.
    Pearce ME; Yu A; Alvarez M; Bartlett SR; Binka M; Jeong D; Clementi E; Adu P; Wilton J; Yoshida EM; Pick N; Buxton JA; Wong J; Jassem A; Krajden M; Janjua NZ
    PLoS One; 2020; 15(12):e0244575. PubMed ID: 33382774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.
    Guiltinan AM; Kaidarova Z; Custer B; Orland J; Strollo A; Cyrus S; Busch MP; Murphy EL
    Am J Epidemiol; 2008 Mar; 167(6):743-50. PubMed ID: 18203734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
    Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
    Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
    Makuza JD; Jeong D; Binka M; Adu PA; Cua G; Yu A; Velásquez García HA; Alvarez M; Wong S; Bartlett S; Karim ME; Yoshida EM; Ramji A; Krajden M; Janjua NZ
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
    Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
    J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.
    Kielland KB; Skaug K; Amundsen EJ; Dalgard O
    J Hepatol; 2013 Jan; 58(1):31-7. PubMed ID: 22960427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.
    Merrall EL; Bird SM; Hutchinson SJ
    Int J Drug Policy; 2012 Jan; 23(1):24-32. PubMed ID: 21719267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.